# Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients

> **NCT04599608** · — · UNKNOWN · sponsor: **Imperial College London** · enrollment: 248 (estimated)

## Conditions studied

- Advanced Cancer
- Metastatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04599608
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02
- **Primary completion:** 2024-02
- **Final completion:** 2026-01
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04599608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04599608, "Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04599608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*